XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2016/10/31/abbvie-v-amgen-the-parties-request-a-bench-trial-in-november-2019/20%Monthly2018-05-24 21:32
https://www.bigmoleculewatch.com/2016/10/31/abbvie-v-amgen-amgen-agrees-to-comply-with-the-bpcia-notice-of-commercial-marketing-requirements/20%Monthly2018-01-10 21:33
https://www.bigmoleculewatch.com/2016/10/31/enbrel-ireland-price-cut/20%Monthly2018-01-10 20:14
https://www.bigmoleculewatch.com/2016/10/28/amgen-unlikely-to-launch-amjevita-biosimilar-before-2018/20%Monthly2018-01-10 20:13
https://www.bigmoleculewatch.com/2016/10/28/sandozs-pegfilgrastim-approval-delayed/20%Monthly2018-01-10 20:13
https://www.bigmoleculewatch.com/2016/10/26/fda-to-issue-draft-guidance-on-interchangeability-by-end-of-year/20%Monthly2016-10-26 19:45
https://www.bigmoleculewatch.com/2016/10/25/catalent-biosimilars-manufacturing-update/20%Monthly2018-01-10 20:11
https://www.bigmoleculewatch.com/2016/10/25/mylan-files-amicus-brief-in-support-of-certiorari-in-amgen-v-apotex/20%Monthly2018-05-25 16:47
https://www.bigmoleculewatch.com/2016/10/24/janssen-v-celltrion-janssen-appeals-judgment-invalidating-the-471-patent/20%Monthly2018-05-25 16:44
https://www.bigmoleculewatch.com/2016/10/21/fujifilm-kyowa-kirin-biologics-adalimumab-trial-results/20%Monthly2018-10-10 17:21
https://www.bigmoleculewatch.com/2016/10/20/mylan-files-amicus-brief/20%Monthly2018-05-25 16:43
https://www.bigmoleculewatch.com/2016/10/20/norwegian-study-concludes-infliximab-biosimilar-not-inferior-to-remicade/20%Monthly2018-01-10 20:08
https://www.bigmoleculewatch.com/2016/10/19/ptab-denies-institution-on-biogens-tysabri-patent/20%Monthly2018-01-10 20:07
https://www.bigmoleculewatch.com/2016/10/19/economic-times-of-india-report-suggests-that-indian-biosimilars-market-may-reach-40-billion-usd-by-2030/20%Monthly2016-10-19 17:22
https://www.bigmoleculewatch.com/2016/10/18/biosimilars-council-files-amicus-brief-in-support-of-apotexs-petition-for-certiorari-in-amgen-v-apotex/20%Monthly2018-05-25 16:42
https://www.bigmoleculewatch.com/2016/10/17/janssen-v-celltrion-district-court-schedules-hearing-on-motion-to-dismiss/20%Monthly2018-05-25 16:41
https://www.bigmoleculewatch.com/2016/10/17/breaking-news-pfizer-inflectra/20%Monthly2018-01-10 19:51
https://www.bigmoleculewatch.com/2016/10/14/amgen-v-hospira-epoetin-alfa-district-court-lets-in-new-infringement-theories-not-new-defendants/20%Monthly2018-05-25 16:40
https://www.bigmoleculewatch.com/2016/10/14/medpac-meets-to-discuss-biosimilars/20%Monthly2017-05-15 17:56
https://www.bigmoleculewatch.com/2016/10/13/merck-sharp-dohme-files-ipr-petition-on-genentechs-cabilly-patent/20%Monthly2018-01-10 19:49
https://www.bigmoleculewatch.com/2016/10/12/litigation-update-in-abbvie-v-amgen-abbvies-answer-filed-in-response-to-amgens-counterclaims/20%Monthly2018-05-25 16:39
https://www.bigmoleculewatch.com/2016/10/12/ct-p10-shows-equivalent-pharmacokinetic-and-comparable-efficacy-with-rituximab/20%Monthly2018-01-10 19:48
https://www.bigmoleculewatch.com/2016/10/11/fda-accepts-coheruss-abla-for-neulasta-biosimilar/20%Monthly2018-05-25 16:37
https://www.bigmoleculewatch.com/2016/10/11/amgen-v-apotex-appeal-filgrastim-pegfilgrastim/20%Monthly2018-05-25 16:38
https://www.bigmoleculewatch.com/2016/10/11/new-results-presented-at-esmo-mercks-keytruda-has-potential-to-be-used-as-first-line-therapy-for-non-small-cell-lung-cancer/20%Monthly2018-02-02 16:03
https://www.bigmoleculewatch.com/2016/10/07/push-to-lower-prescription-drug-prices-could-have-an-effect-on-biosimilars-market/20%Monthly2017-03-09 21:30
https://www.bigmoleculewatch.com/2016/10/06/johnson-johnsons-drug-outperformed-humira-in-final-stage-psoriasis-study/20%Monthly2018-01-10 19:44
https://www.bigmoleculewatch.com/2016/10/06/deal-watch-teva-and-celltrion-announce-biosimilar-commercial-partnership/20%Monthly2018-01-10 19:43
https://www.bigmoleculewatch.com/2016/10/05/cert-denied-on-scope-of-271e1-safe-harbor/20%Monthly2018-06-26 19:28
https://www.bigmoleculewatch.com/2016/10/05/samsung-biologics-ipo-plans-for-november-listing/20%Monthly2018-01-10 19:42
https://www.bigmoleculewatch.com/2016/10/04/upcoming-biosimilars-conferences/20%Monthly2016-10-04 01:08
https://www.bigmoleculewatch.com/2016/10/03/litigation-update-answer-filed-in-abbvie-v-amgen/20%Monthly2018-05-25 16:36